Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of anicells is 0.8% (low). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
No director data processed yet.
To directors Publications
No State Gazette publications linked.
To publications Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsMore than 3 years active
Founded in 2019 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.8%
Low
0%0,5%1,5%4%10%≥25%
Young company
+Lower-failure-rate sector
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Vervaardiging van overige farmaceutische producten21209Vervaardiging van overige farmaceutische producten21209Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110Vervaardiging van overige farmaceutische producten21209Vervaardiging van overige farmaceutische producten21209
Primary activity highlighted.
Names & trade names
| Legal nameNL | anicells |
Registered office
Galileilaan 21
2845 Niel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.